1. Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis. Issue 5 (24th August 2007) Authors: Gengenbacher, M; Sebald, H-J; Villiger, P M; Hofstetter, W; Seitz, M Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 5(2008) Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗